Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-25 @ 9:33 PM
Study NCT ID:
NCT04218851
Status:
COMPLETED
Last Update Posted:
2025-01-14
First Post:
2020-01-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-18
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-03
First Submit QC Date:
None
Study First Post Date:
2020-01-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-05
Results First Submit QC Date:
None
Results First Post Date:
2025-01-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-09
Last Update Post Date:
2025-01-14
Last Update Post Date Type:
ACTUAL